Targeting C/EBPα overcomes primary resistance and improves the efficacy of FLT3 inhibitors in acute myeloid leukaemia.
Wang H, Luo G, Hu X, Xu G, Wang T, Liu M, Qiu X, Li J, Fu J, Feng B, Tu Y, Kan W, Wang C, Xu R, Zhou Y, Yang J, Li J.
Wang H, et al. Among authors: wang t, wang c.
Nat Commun. 2023 Apr 5;14(1):1882. doi: 10.1038/s41467-023-37381-4.
Nat Commun. 2023.
PMID: 37019911
Free PMC article.